Hisamitsu Pharmaceutical Co., Inc.
TSE:4530.T
3,948 (JPY) • At close September 19, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Hisamitsu Pharmaceutical Co., Inc. |
Symbool | 4530.T |
Munteenheid | JPY |
Prijs | 3,948 |
Beurswaarde | 289,558,633,812 |
Dividendpercentage | 2.25% |
52-weken bereik | 3,600 - 5,497 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Kazuhide Nakatomi |
Website | https://www.hisamitsu.co.jp |
An error occurred while fetching data.
Over Hisamitsu Pharmaceutical Co., Inc.
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (JPY)
Cijfers zijn in miljoenen (JPY)